ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancers and is clinically defined as lacking expression of the estrogen receptor (ER) and progesterone receptor (PR) and overexpression of the human epidermal growth factor receptor (HER) 2.